Nexalin Technology, Inc. (NXL)
NASDAQ:NXL
US Market
Holding NXL?
Track your performance easily

Nexalin Technology, Inc. (NXL) Stock Price & Analysis

107 Followers

NXL Stock Chart & Stats


Financials

Annual

Ownership Overview

14.47%0.46%0.83%84.24%
14.47% Insiders
0.83% Other Institutional Investors
84.24% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

NXL FAQ

What was Nexalin Technology, Inc.’s price range in the past 12 months?
Nexalin Technology, Inc. lowest stock price was $0.25 and its highest was $4.05 in the past 12 months.
    What is Nexalin Technology, Inc.’s market cap?
    Currently, no data Available
    When is Nexalin Technology, Inc.’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Nexalin Technology, Inc.’s earnings last quarter?
    Currently, no data Available
    Is Nexalin Technology, Inc. overvalued?
    According to Wall Street analysts Nexalin Technology, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Nexalin Technology, Inc. pay dividends?
      Nexalin Technology, Inc. does not currently pay dividends.
      What is Nexalin Technology, Inc.’s EPS estimate?
      Nexalin Technology, Inc.’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Nexalin Technology, Inc. have?
      Nexalin Technology, Inc. has 10,586,562 shares outstanding.
        What happened to Nexalin Technology, Inc.’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Nexalin Technology, Inc.?
        Currently, no hedge funds are holding shares in NXL
        ---

        Company Description

        Nexalin Technology, Inc.

        Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        NextCure
        Nevro Corp
        InMode
        SAGE Therapeutics
        Popular Stocks
        ---
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis